Showing results (1971-1980 of 4,518) with videos related to

Sort By:
Pageof 452
Advances in Therapy|January 7, 2026
Diabetes Remission in Drug-Naïve Patients with Type 2 Diabetes After Efsubaglutide Alfa TreatmentRui Sun, Kun Wang, Guoyue Yuan, et al.
Advances in Therapy|December 27, 2025
Artificial Intelligence Software for Detecting Paroxysmal Atrial Fibrillation from Sinus Rhythm Monitor ECG: Development and Clinical TrialYuichi Tamura, Tomohiro Takata, Hirohisa Taniguchi, et al.
Advances in Therapy|April 18, 2020
Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional StudyKlaas Heinemann, Bruno Imthurn, Lena Marions, et al.
Advances in Therapy|April 20, 2020
Long-Term Safety and Efficacy of Sitagliptin for Type 2 Diabetes Mellitus in Japan: Results of a Multicentre, Open-Label, Observational Post-Marketing Surveillance StudyKen Yoshikawa, Akira Tsuchiya, Tomoyuki Kido, et al.
Advances in Therapy|March 13, 2023
Treatment Patterns Among Patients with Attention-Deficit/Hyperactivity Disorder and Comorbid Anxiety and/or Depression in the United States: A Retrospective Claims AnalysisJeff Schein, Ann Childress, Patrick Gagnon-Sanschagrin, et al.
Advances in Therapy|March 15, 2023
Cost-Effectiveness of Brentuximab Vedotin Versus Physician's Choice of Methotrexate or Bexarotene for the Treatment of Cutaneous T-cell Lymphoma in CanadaDavid Elsea, Kerry J Savage, Cameron Lilley, et al.
Advances in Therapy|March 15, 2023
Management of Older Patients with Head and Neck Cancer: A Comprehensive ReviewLeandro L Matos, Alvaro Sanabria, K Thomas Robbins, et al.
Advances in Therapy|March 3, 2023
Cost Analysis of Aprotinin Reintroduction in French Cardiac Surgery Centres: A Real-World Data-Based AnalysisPascal Colson, Jean-Luc Fellahi, Philippe Gaudard, et al.
Advances in Therapy|March 25, 2023
Temperature Control After Cardiac Arrest: A Narrative ReviewSamantha Fernandez Hernandez, Brooke Barlow, Vera Pertsovskaya, et al.
Advances in Therapy|March 22, 2023
Cost-Effectiveness of Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel in the Third-Line or Later Treatment Setting for Relapsed or Refractory Large B-cell Lymphoma in the United StatesChristopher Parker, Fei Fei Liu, Kristen A Deger, et al.
Pageof 452